Linden brings integrated investment, operating, and human capital proficiency to every one of our buyout funds’ portfolio companies. Our investment professionals have extensive experience in private equity, from sourcing and transaction structuring to value creation, exit planning and fund administration. Our operating partners, executives generally hailing from prominent healthcare companies, not only serve on our portfolio company boards, but also are involved in nearly every aspect of growing our companies. Supplementing the team is our Human Capital team, an in-house resource dedicated to shaping teams that drive strategic and operational excellence, as well as recruiting investment talent, and supporting Human Resources administration

We build long-term relationships with some of the largest healthcare companies in the world. Through these relationships, we maintain an active pulse on the industry and a direct pipeline to opportunities. We believe our relationships help secure advantageous sourcing, strategic alternatives for non-core operations, and proprietary investment opportunities, including our ability to provide strategic capital for joint bids with our corporate partners. We actively monitor the strategic activities of many of the largest companies, staying abreast of real-time developments and opportunities for dialogue, partnerships and alliances.

The success of our portfolio company often directly reflects our investment in management relationships. In every one of our buyout fund investments, management participates with us in ownership of the business. This co-ownership is deeper than structure; it’s grounded in our principles and values of partnership. We maintain open communication and active engagement with our management teams, providing the resources and support necessary for companies to thrive.

We have cultivated an expansive network of executive, operating, management, regulatory, reimbursement, and scientific advisors from what we believe to be renowned corporations, professional firms, consulting firms, government entities and academic institutions across the world. These individuals can provide invaluable insight into developments and trends in healthcare, helping to identify the type of industry shifts that impact our decisions. Their added value often extends to advice, strategic partnerships, and guidance through all phases of our investments, from initial sourcing and due diligence to value creation and exit planning.